Ongoing research in the field of
prevention and effective treatment of kidney stone diseases is expected to
impact the Kidney
Stone Management Devices Market. For instance, in 2017, Duke Clinical
Research Institute (DCRI), scientific data research center for the Urinary
Stone Disease Research Network, launched a two year clinical trial to determine
the ways to prevent recurrence of kidney stones. Moreover, in 2016, American
Urological Association (AUA) released new guidelines for surgical treatment of
patients with renal stones. The most pertinent change was decision about
treatment and therapy for kidney stones, which should be shared between
physician and patients. These guidelines state expert recommendations in
relation to treatment of renal stones, small hard mineral deposits inside the
kidneys and ureteral stones.
Urolithiasis is the most frequent
and common urological disease, which involves stone formation in the kidney,
bladder, and urinary tract. The reasons behind stone development in above
mentioned areas are mainly associated with decreased urine volume and increased
excretion of stone-forming substances such as oxalate, calcium, cysteine,
urate, phosphate, and xanthine. Kidney stones can be treated effectively, due to
presence of advanced methods and associated medical devices. According to the
American Urologic Association (AUA), direct and associated treatment cost
related to kidney stone diagnosis and management has increased over the past
few years. Despite recent advancements in therapeutic and surgical treatment
techniques, the overall health care expenditure for the kidney stone disease
management has increased. According to National Center for Biotechnology
Information (NCBI), the cost for medical management of kidney stones is
expected to reach to US$ 1.24 Bn annually in the U.S. by 2030. Cost containment
for the patients has been made possible by technological development in terms
of shorter duration hospital stays and more minimally invasive surgical
procedures.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1030
Kidney stones can occur in one or
both kidneys. It can affect people between ages of 30 to 60 years according to
the National Health Service (NHS). Furthermore, the global prevalence of kidney
stones annually is three in 20 men and two in 20 women according to NHS. The
U.S. National Health and Nutrition Examination Survey (NHANES), published in
2012, stated that the prevalence of kidney stones in men was 10.6% and was 7.1%
in women.
New product launches and ongoing
research on prevention and treatment of kidney stones is expected to boost the
market growth over the forecast period
Technological advancements and
innovative product launches have allowed for therapy optimization and better
management of the stones irrespective of their sizes. Terumo Corporation
launched GLIDEWAY ureteral access sheath, which was used in minimally invasive
urologic procedures in 2014. Boston Scientific launched LithoVue single use
digital flexible ureteroscopes in Europe in 2016, which provided high-quality
visualization better than leading ureteroscopes at the time.
Technological advancement in the
surgical procedures requiring minimal invasion is expected to boost the growth
of the kidney stone management devices market
Advancements in the surgical
procedures to treat kidney stones such as Extracorporeal Shock Wave Lithotripsy
(ESWL), Ureteroscopy, and Percutaneous Nephrolithotomy have simplified the
surgical procedures over the years. Advent of high resolution imaging devices,
increased availability of flexible ureteroscopes and lithotripsy devices, and
decreased invasiveness of the procedures have helped to favorably shape the
kidney stone management devices market.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/kidney-stone-management-devices-market-1030
Smaller and more flexible
ureteroscopes namely LithoVue and effective stone retrieval devices have been
made available by the industry players to increase the efficacy of the surgical
procedures. These cost-effective techniques have allowed faster recovery with
few treatment cycles requiring minimal sedation. Ureteroscopy is being
preferred more currently, owing to advantages, such as immediate stone removal
and low risk of complications, especially in treatment of symptomatic stones
located in pelvic kidneys, where this technique excels over the other two.
Increasing reimbursement support from government and private sources for
medical devices such as separate reimbursements for physician payment, hospital
outpatient, and hospital inpatient by Medicare as well as implementation of the
Affordable Care Act (ACA) in the U.S. has been a major growth factor for the
kidney stone management devices market.
Key players in the kidney stone
management devices market
Some of the key players operating
in the kidney stone management devices market include Bard Medical Division,
Coloplast Group, Allengers Medical Systems, Boston Scientific Corporation, Cook
Medical, Electro Medical Systems, Lumenis Ltd., Storz Medical AG, Dornier
Medtech, and Richard Wolf GmbH.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1030
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment